About Andromed Rotterdam
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kowa Research Europe
6
Boehringer Ingelheim
2
Medical Research Laboratories International
2
Ironwood Pharmaceuticals, Inc.
1
Merz Pharmaceuticals GmbH
1
Novartis Pharmaceuticals
1
The Medicines Company
1
Clinical Trials at Andromed Rotterdam
During the past decade, Andromed Rotterdam conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy
2003-10-01
2005-04-01
Terminated
120
Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy
2004-10-01
2005-04-01
Terminated
50
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients
2005-09-01
2006-05-01
Completed
962
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
2005-12-01
2007-06-01
Completed
418
Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
2006-04-01
2007-08-01
Completed
1,695
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-06-01
2007-12-01
Completed
545
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Andromed Rotterdam" #1 sponsor was "Kowa Research Europe" with 6 trials, followed by "Boehringer Ingelheim" with 2 trials
sponsored, "Medical Research Laboratories International" with 2 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored and "Merz Pharmaceuticals GmbH"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Andromed Rotterdam"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Andromed Rotterdam
According to Clinical.Site data, the most researched conditions in "Andromed Rotterdam" are
"Dyslipidemia" (4 trials), "Familial Hypercholesterolemia" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Dyslipidemias" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "Andromed Rotterdam" in a lesser frequency.
Clinical Trials Intervention Types at Andromed Rotterdam
Most popular intervention types in "Andromed Rotterdam" are "Drug" (14 trials). Other intervention types were less common.
The name of intervention was led by "Pitavastatin" (6 trials), "Atorvastatin" (3 trials), "Placebo" (2 trials), "ALN-PCSSC" (1 trials) and "Evolocumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Andromed Rotterdam
The vast majority of trials in "Andromed Rotterdam" are
14 trials for "All" genders.
Clinical Trials Status at Andromed Rotterdam
Currently, there are NaN active trials in "Andromed Rotterdam".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Andromed Rotterdam,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Andromed Rotterdam, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".